Cancer Supportive Care Drugs Market

Cancer Supportive Care Drugs Market By Therapeutic Class (ESA, G-CSFs, Antiemetics, Bisphosphonates, Opioids, NSAIDs) By Application (Breast Cancer, Stomach Cancer Colorectal Cancer, Liver Cancer, Prostate Cancer) By Distribution Channel (Drug pharmacies/ Retail pharmacies, Hospital Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2031

Pharma & Healthcare | March 2023 | Report ID: EMR0055 | Pages: 215

The global cancer supportive care drugs market size was reached at USD 19.67 billion in 2022 and it is projected to hit around USD 25 billion by 2031, growing at a CAGR of 2.10% during the forecast period from 2023 and 2031. The rising awareness about adverse effects caused by prolonged cancer treatment is expected to boost the growth of the cancer supportive care drugs market during the forecast period.

Cancer supportive care drugs offer wraparound care for cancer patients, and they also help healthcare administration navigate the illness. Cancer supportive care is a well-recognized discipline that plays around multiple aspects of medical care, including the physical, psychological, and mental issues cancer patients face. The evolution of supportive oncology has focused on the improvement of cancer-supportive care drugs that can indicate the urgency of pain.

Cancer supportive care drugs are widely used, and oncologists prefer to use them right away after a cancer diagnosis. According to the National Cancer Institute, supportive care drugs can improve both physical and mental health.

Supportive care drugs have been shown to include post-therapy care for cancer patients. Cancer supportive care drugs help cancer patients avoid treatment side effects and complications. Chemotherapy is one of the most effective cancer treatments or therapies. Prolonged chemotherapy, on the other hand, may increase toxicity and reduce quality of life; supportive cancer care drugs address these side effects of cancer treatment. Therapists, palliative care specialists, nutritionists, pain care specialists, and medical advisors participate in the supportive cancer care drugs or medicines delivery sessions. Cancer-supportive care medications have the potential to improve healthcare outcomes and quality of life.


Cancer Supportive Care Drugs Market REPORT SCOPE & SEGMENTATION

Report Attribute


Estimated Market Value (2022)

20.96 Bn

Projected Market Value (2031)

25 Bn

Base Year


Forecast Years

2023 - 2031

Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- By Therapeutic Class, By Distribution Channel, By Application & By Region

Segments Covered

By Therapeutic Class, By Distribution Channel, By Application & By Region

Forecast Units

Value (USD Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2023 to 2031

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Report Coverage

Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Delivery Format

Delivered as an attached PDF and Excel through email, according to the purchase option.


Growth Factors:

The global supportive care drugs market is expected to undergo a significant shift during the forecast period as the supportive oncology sector improves globally. In the last two decades, an unhealthy diet and sedentary lifestyles have increased the prevalence of cancer across the globe. According to the World Health Organization (WHO), approximately 4 lakh children develop cancer each year. Cancer patients' pain and side effects are reduced by supportive care drugs; the rising prevalence of childhood cancer is expected to increase demand for supportive care drugs in the healthcare sector.

The growing concern about cancer-related mortality has pushed the oncology sector to provide advanced and accountable treatment for cancer patients; the global focus on oncology research is fueling the growth of the cancer-supportive care drugs market. Various cancer treatments frequently have serious adverse effects on the human body, and rising awareness about the severe side effects caused by prolonged cancer treatment is driving market growth.

Cancer supportive care drug demand is expected to rise in high-income countries where comprehensive healthcare services are widely available. The rising preference for targeted molecule therapies for cancer patients, on the other hand, will stifle the growth of the cancer-supportive care drugs market.


Key Benefits of the Report

  • This study presents an analytical depiction of the Cancer Supportive Care Drugs industry along with current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to market key drivers, restraints, and opportunities, along with detailed analysis of the Cancer Supportive Care Drugs Market share.
  • The current market is quantitatively analyzed to highlight the Cancer Supportive Care Drugs Market's growth scenario.
  • Porter's five forces research demonstrates the market power of suppliers and buyers.
  • The report provides a detailed Cancer Supportive Care Drugs market analysis based on competitive intensity and how the competition will take shape in the coming years.


Regional Analysis:

North America holds the largest share of the global market for cancer supportive care drugs; Over the analyzed period, the region is expected to maintain its dominance. The rapid adoption of pharmaceutical industry advancements is seen as a significant driver of the growth of the cancer supportive care drugs market in North America. The presence of well-established vendors in the supportive care market will keep North America's dominance in the cancer supportive care drugs market throughout the forecast period. Furthermore, rising preferences for supportive care for newly diagnosed cancer patients are driving market growth in North America. However, strict restrictions on opioid prescription and sale are impeding the growth of the cancer supportive care drugs market in North America.

Because of the increasing demand for supportive care in the oncology sector, Asia Pacific is the fastest-growing region of the global cancer supportive care drugs market. Chemotherapy is widely used to treat cancer patients in the region. The rising number of chemotherapies in urban areas is expected to drive growth in the Asia Pacific cancer supportive care drugs market. Furthermore, rising vendor investments in oncology research will drive market growth in Asia Pacific.

Germany, England, and the United Kingdom are expected to contribute the most to Europe's cancer supportive care drugs market. The rapid increase in female breast cancer cases has increased demand for cancer supportive care drugs and palliative care in the region. Several private companies and governmental organizations are investing heavily in R&D activities in the oncology research sector in order to provide more advanced and dependable treatment for cancer patients; this factor is expected to fuel market growth in Europe during the forecast period. The European research community and healthcare sector are focused on implementing targeted therapies for cancer patients; this factor is likely to stymie the region's growth in the cancer supportive care drugs market.

Competitive Landscape

The report provides a competitive landscape on both the quantitative and qualitative research of the Cancer Supportive Care Drugs Market. The report also provides detailed insights on the development methods used by the key market players. The report offers deep research on the key market players and details on the competitiveness of these players. The main business strategies used by these players, such as mergers and acquisitions (M&A), collaborations, affiliations, and contracts, are also discussed and analyses in the report. For each competitor, the report studies their global presence, service offerings, competitors, and specifications. The main players covered by the study on the global electrical equipment market are:

  • Merck & Co.
  • Novartis AG
  • F. Hoffman-La Roche AG
  • Johnson & Johnson
  • GlaxoSmithKline Plc
  • Helsin Healthcare SA
  • Baxter International Inc


Cancer Supportive Care Drugs Market Report Segmentation



By Therapeutic Class

  • ESA (Erythropoiesis Stimulating Agents)
  • G-CSFs (Granulocyte Colony Stimulating Factors)
  • Antiemetics
  • Bisphosphonates
  • Opioids
  • NSAIDs (Non-Steroidal Auto Inflammatory Drugs)

By Application

  • Breast Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Liver Cancer
  • Prostate Cancer

By Distribution Channel

  • Drug pharmacies/ Retail pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Customization Scope

  • Available upon request


  • Available upon request


The Report Answers Questions Such As:

  • What is the potential opportunity for the Cancer Supportive Care Drugs Market.
  • What are the major drivers, restraints, and opportunities of the Cancer Supportive Care Drugs Market.
  • What is the market share of the leading segments and sub-segments of the Cancer Supportive Care Drugs Market in the forecast period (2023-2031).
  • How is each segment of the Cancer Supportive Care Drugs Market expected to grow during the forecast period.
  • What is the expected revenue to be generated by each of the segments by the end of 2031.
  • What are the key development strategies implemented by the key players to stand out in this Cancer Supportive Care Drugs Market.
  • What is the preferred business model used for building Cancer Supportive Care Drugs Market.
  • Which area of application is expected to be the highest revenue generator in the Cancer Supportive Care Drugs Market during the forecast period.
  • Which end-user segment is expected to be the highest revenue generator in this industry during the forecast period.
  • What is the potential of Cancer Supportive Care Drugs Market in the emerging countries during the forecast period.


Research Methodology

Our research methodology has always been the key differentiating reason which sets us apart in comparison from the competing organizations in the industry. Our organization believes in consistency along with quality and establishing a new level with every new report we generate; our methods are acclaimed and the data/information inside the report is coveted. Our research methodology involves a combination of primary and secondary research methods. Data procurement is one of the most extensive stages in our research process. Our organization helps in assisting the clients to find the opportunities by examining the market across the globe coupled with providing economic statistics for each and every region.  The reports generated and published are based on primary & secondary research. In secondary research, we gather data for global Market through white papers, case studies, blogs, reference customers, news, articles, press releases, white papers, and research studies. We also have our paid data applications which includes hoovers, Bloomberg business week, Avention, and others.

Data Collection

Data collection is the process of gathering, measuring, and analyzing accurate and relevant data from a variety of sources to analyze market and forecast trends. Raw market data is obtained on a broad front. Data is continuously extracted and filtered to ensure only validated and authenticated sources are considered. Data is mined from a varied host of sources including secondary and primary sources.

Primary Research

After the secondary research process, we initiate the primary research phase in which we interact with companies operating within the market space. We interact with related industries to understand the factors that can drive or hamper a market. Exhaustive primary interviews are conducted. Various sources from both the supply and demand sides are interviewed to obtain qualitative and quantitative information for a report which includes suppliers, product providers, domain experts, CEOs, vice presidents, marketing & sales directors, Type & innovation directors, and related key executives from various key companies to ensure a holistic and unbiased picture of the market. 

Secondary Research

A secondary research process is conducted to identify and collect information useful for the extensive, technical, market-oriented, and comprehensive study of the market. Secondary sources include published market studies, competitive information, white papers, analyst reports, government agencies, industry and trade associations, media sources, chambers of commerce, newsletters, trade publications, magazines, Bloomberg BusinessWeek, Factiva, D&B, annual reports, company house documents, investor presentations, articles, journals, blogs, and SEC filings of companies, newspapers, and so on. We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

Top-Down Approach & Bottom-Up Approach

In the top – down approach, the Global Batteries for Solar Energy Storage Market was further divided into various segments on the basis of the percentage share of each segment. This approach helped in arriving at the market size of each segment globally. The segments market size was further broken down in the regional market size of each segment and sub-segments. The sub-segments were further broken down to country level market. The market size arrived using this approach was then crosschecked with the market size arrived by using bottom-up approach.

In the bottom-up approach, we arrived at the country market size by identifying the revenues and market shares of the key market players. The country market sizes then were added up to arrive at regional market size of the decorated apparel, which eventually added up to arrive at global market size.

This is one of the most reliable methods as the information is directly obtained from the key players in the market and is based on the primary interviews from the key opinion leaders associated with the firms considered in the research. Furthermore, the data obtained from the company sources and the primary respondents was validated through secondary sources including government publications and Bloomberg.

Market Analysis & size Estimation

Post the data mining stage, we gather our findings and analyze them, filtering out relevant insights. These are evaluated across research teams and industry experts. All this data is collected and evaluated by our analysts. The key players in the industry or markets are identified through extensive primary and secondary research. All percentage share splits, and breakdowns have been determined using secondary sources and verified through primary sources. The market size, in terms of value and volume, is determined through primary and secondary research processes, and forecasting models including the time series model, econometric model, judgmental forecasting model, the Delphi method, among Flywheel Energy Storage. Gathered information for market analysis, competitive landscape, growth trends, product development, and pricing trends is fed into the model and analyzed simultaneously.

Quality Checking & Final Review

The analysis done by the research team is further reviewed to check for the accuracy of the data provided to ensure the clients’ requirements. This approach provides essential checks and balances which facilitate the production of quality data. This Type of revision was done in two phases for the authenticity of the data and negligible errors in the report. After quality checking, the report is reviewed to look after the presentation, Type and to recheck if all the requirements of the clients were addressed.

Frequently Asked Questions


Avail PDF Sample Reports